1 study found for:    22209479 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Kronos Early Estrogen Prevention Study (KEEPS)
Conditions: Menopause;   Arteriosclerosis
Interventions: Drug: Conjugated equine estrogens 0.45 mg/day;   Drug: Transdermal estradiol, 50 mcg/day;   Drug: Micronized progesterone, 200 mg/day x 12 d/month;   Drug: CEE , progesterone, estradiol patch or placebo for each;   Drug: CEE, progesterone, transdermal patch or the placebo

Indicates status has not been verified in more than two years